Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 91,500 |
5 mg | 在庫あり | ¥ 223,000 |
10 mg | 在庫あり | ¥ 296,000 |
25 mg | 在庫あり | ¥ 447,500 |
50 mg | 在庫あり | ¥ 601,500 |
100 mg | 在庫あり | ¥ 810,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 259,500 |
説明 | SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability. |
In vitro | SRI37892 block Wnt/β-catenin signaling in HEK293 cells induced by Wnt3A and LRP6 with IC50 of 0.66 μM and 0.78 μM, respectively[1]. |
分子量 | 465.53 |
分子式 | C26H19N5O2S |
CAS No. | 1030769-75-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (107.4 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SRI 37892 1030769-75-5 Cytoskeletal Signaling Stem Cells Wnt/beta-catenin SRI37892 SRI-37892 Inhibitor inhibitor inhibit